Leidos Selects Immunovaccine’s DepoVax(TM) Platform to Evaluate Its USAID-Backed Malaria Vaccine Research
HALIFAX, NOVA SCOTIA–(Marketwired – June 23, 2016) – Immunovaccine Inc. (“Immunovaccine” or the “company”) (TSX:IMV)(OTCQX:IMMVF), a clinical stage [...]